J D Horowitz Selected Research

J D Horowitz Research Topics

Disease

8	Acute Coronary Syndrome 09/2019 - 07/2000
8	Heart Failure 12/2014 - 08/2000
3	Stable Angina 09/2019 - 06/2001
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2019 - 11/2013
3	Unstable Angina 08/2010 - 07/2000
3	Myocardial Infarction 08/2010 - 07/2000
2	Disease Progression 01/2020 - 07/2012
2	Hemorrhage 09/2019 - 09/2014
2	Atrial Fibrillation 11/2016 - 09/2014
2	Stroke (Strokes) 09/2014 - 08/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2013 - 10/2011
1	Hyperglycemia 09/2019
1	Heart Diseases (Heart Disease) 02/2015
1	Embolism (Embolus) 09/2014
1	Thrombosis (Thrombus) 11/2013
1	Inflammation (Inflammations) 05/2012
1	Reperfusion Injury 05/2012
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2011
1	Hypertension (High Blood Pressure) 10/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2011
1	Left Ventricular Dysfunction 06/2011
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 06/2011
1	ST Elevation Myocardial Infarction 08/2010
1	Angina Pectoris 01/2004
1	Chest Pain (Chest Pains) 06/2001
1	Coronary Disease (Coronary Heart Disease) 06/2001
1	Hyperkalemia 01/2001
1	Hypotension (Low Blood Pressure) 01/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2000
1	Diabetes Mellitus 12/2000
1	Ischemia 12/2000
1	Sudden Death 08/2000

Drug/Important Bio-Agent (IBA)

6	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2013 - 06/2001
4	Lisinopril (Prinivil)FDA LinkGeneric 09/2001 - 08/2000
3	Clopidogrel (Plavix)FDA Link 02/2015 - 08/2010
3	PerhexilineIBA 06/2004 - 12/2000
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 09/2019 - 02/2015
2	NitratesIBA 12/2014 - 12/2000
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2013 - 10/2011
2	Cytochrome P-450 CYP2C19IBA 11/2013 - 08/2010
2	Nitric Oxide DonorsIBA 10/2011 - 05/2001
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2011 - 06/2011
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2001 - 12/2000
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2001 - 12/2000
1	Purinergic P2Y Receptor AntagonistsIBA 09/2019
1	Iloprost (Ventavis)FDA Link 09/2019
1	Alprostadil (Muse)FDA LinkGeneric 09/2019
1	Galectin 3 (LGALS3)IBA 11/2016
1	Soluble Guanylyl CyclaseIBA 02/2015
1	NitritesIBA 12/2014
1	apixabanIBA 09/2014
1	fibrin fragment D (D-dimer)IBA 09/2014
1	Warfarin (Coumadin)FDA LinkGeneric 09/2014
1	1-isopropyldiazen-1-ium-1,2-diolateIBA 11/2013
1	ChemokinesIBA 05/2012
1	CurcuminIBA 05/2012
1	CytokinesIBA 05/2012
1	C-Reactive ProteinIBA 10/2011
1	Insulin (Novolin)FDA Link 10/2011
1	hydroxide ionIBA 10/2011
1	Vitamin D FDA LinkGeneric 10/2011
1	Biomarkers (Surrogate Marker)IBA 06/2011
1	Prasugrel Hydrochloride FDA Link 08/2010
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2010
1	Heparin (Liquaemin)FDA LinkGeneric 01/2003
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2003
1	Adenosine Diphosphate (ADP)IBA 06/2001
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2001
1	4-hydroxyphenylglycine (oxfenicine)IBA 12/2000
1	paragonIBA 07/2000

Therapy/Procedure

3	Therapeutics 01/2020 - 12/2000
2	Stents 09/2019 - 11/2013
2	Drug Therapy (Chemotherapy) 07/2012 - 07/2000
1	Percutaneous Coronary Intervention 08/2010
1	Drug Tapering 01/2001